LCM
PASG icon

Lynx1 Capital Management’s Passage Bio PASG Stock Holding History

Lynx1 Capital Management’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.29M Buy
673,759
+50,055
+8% +$313K 0.38% 10
2026
Q1 		$4.9M Hold
623,704
– – 0.77% 11
2025
Q4 		$7.36M Hold
623,704
– – 1.49% 9
2025
Q3 		$5.01M Buy
623,704
+160,856
+35% +$1.12M 1.02% 10
2025
Q2 		$3.71M Hold
462,848
– – 1.07% 10
2025
Q1 		$3.27M Hold
462,848
– – 1.17% 11
2024
Q4 		$5.25M Buy
462,848
+41,500
+10% +$541K 1.97% 9
2024
Q3 		$5.9M Buy
421,348
+168,467
+67% +$2.68M 2.09% 8
2024
Q2 		$4.02M Buy
252,881
+10,587
+4% +$259K 1.45% 9
2024
Q1 		$6.54M Buy
242,294
+223,336
+1,178% +$5.37M 1.69% 10
2023
Q4 		$383K Buy
18,958
+9,452
+99% +$130K 0.15% 15
2023
Q3 		$125K Sell
9,506
-48,861
-84% -$803K 0.08% 16
2023
Q2 		$1.1M Sell
58,367
-112,013
-66% -$2.22M 0.72% 13
2023
Q1 		$3.26M Buy
170,380
+2,584
+2% +$70K 2.72% 10
2022
Q4 		$4.63M Buy
167,796
+30,175
+22% +$761K 4.01% 9
2022
Q3 		$3.44M Buy
137,621
+116,550
+553% +$4.59M 3.1% 9
2022
Q2 		$995K Buy
21,071
+15,796
+299% +$738K 0.85% 11
2022
Q1 		$327K Buy
+5,275
New +$435K 0.3% 12

Other funds holding PASG

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $9.19B AUM 25.65% 1-Year Est. Return

Lynx1 Capital Management's PASG Position: Q2 2026 in Review

Lynx1 Capital Management increased its Passage Bio (PASG) stake by 8% in Q2 2026, buying an estimated $313K and bringing the position to 673,759 shares worth $3.29M. The position accounts for 0.38% of the portfolio, ranked #10.

Lynx1 Capital Management first reported a position in PASG in Q1 2022 and has held it in 18 quarters since. The position peaked at $7.36M in Q4 2025. 19 funds tracked by Wall St. Rank hold PASG as of Q2 2026.

  • Lynx1 Capital Management held 673,759 shares of Passage Bio worth $3.29M as of Q2 2026.
  • Lynx1 Capital Management bought 50,055 Passage Bio shares in Q2 2026, an estimated $313K.
  • Passage Bio made up 0.38% of Lynx1 Capital Management's portfolio in Q2 2026, its #10 holding.
  • Lynx1 Capital Management first reported a position in Passage Bio in Q1 2022 and has held it in 18 quarters since.
  • Lynx1 Capital Management's Passage Bio position peaked at $7.36M in Q4 2025.
  • 19 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.

Based on Lynx1 Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.